Eurogentec

CDMO

Belgium

https://www.eurogentec.com/

Is this your company? Claim this profile

Drug Product

Analytical & Bioanalytical Services

Regulatory, Tech Transfer & Support Services

Company Overview

About

Eurogentec is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Formulation Development, Process Development, Scale-up

Therapeutic Areas

Immunology

Rheumatology

Quick Facts

HQ:Belgium

Founded:2018

Employees:2,684

Capabilities & Services

Core Capabilities

Peptide Synthesis
Small Molecule API
Formulation Development

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Inhalation

Containment Capabilities

BSL-2 (Biosafety Level 2)

Production Scales

Phase II

Clinical

Pilot Scale

Markets Served

Europe

Regulatory Approvals

Drug Approval LUDVX5

PMDA · #APR-WY7PX6Q3 · 2021-05-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-5T6VMSAY

Issued: 2020-05-17

Expires: 2025-11-01

EMA GMP Certificate

European Medicines Agency

Cert #: CERT-NGQRLPU3

Issued: 2020-09-09

Expires: 2025-12-26

ISO 9001:2015

International Organization for Standardization

Cert #: CERT-GJGD1ERC

Issued: 2020-07-13

Expires: 2025-01-13

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about Eurogentec

Eurogentec is headquartered in Belgium.
Eurogentec was founded in 2018.
Eurogentec has 2,684 employees.
Eurogentec's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.

Find CDMOs like Eurogentec

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in Belgium CDMOs in Europe Small Molecule API CDMOs Formulation Development CDMOs Inhalation CDMOs BSL-2 (Biosafety Level 2) CDMOs